Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial (Q39382188)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial |
scientific article |
Statements
1 reference
Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial (English)
1 reference
Philippe Desprès
1 reference
Bernd Jilma
1 reference
Michael Schwameis
1 reference
Katrin Ramsauer
1 reference
Christa Firbas
1 reference
Matthias Müllner
1 reference
Robert J Putnak
1 reference
Stephen J Thomas
1 reference
Erich Tauber
1 reference
Frederic Tangy
1 reference
2 March 2015
1 reference
1 reference
Identifiers
1 reference